Glassman Wealth Services’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-50
| Closed | -$16.1K | – | 406 |
|
2023
Q4 | $16.1K | Buy |
50
+28
| +127% | +$9.04K | ﹤0.01% | 744 |
|
2023
Q3 | $7.89K | Sell |
22
-16
| -42% | -$5.74K | ﹤0.01% | 922 |
|
2023
Q2 | $14.4K | Buy |
38
+14
| +58% | +$5.31K | ﹤0.01% | 709 |
|
2023
Q1 | $11.5K | Buy |
24
+6
| +33% | +$2.87K | ﹤0.01% | 781 |
|
2022
Q4 | $7.57K | Buy |
18
+1
| +6% | +$421 | ﹤0.01% | 904 |
|
2022
Q3 | $7K | Buy |
17
+6
| +55% | +$2.47K | ﹤0.01% | 894 |
|
2022
Q2 | $5K | Sell |
11
-3
| -21% | -$1.36K | ﹤0.01% | 984 |
|
2022
Q1 | $8K | Buy |
14
+3
| +27% | +$1.71K | ﹤0.01% | 884 |
|
2021
Q4 | $8K | Buy |
11
+9
| +450% | +$6.55K | ﹤0.01% | 853 |
|
2021
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 1285 |
|
2021
Q2 | $1K | Buy |
2
+1
| +100% | +$500 | ﹤0.01% | 1237 |
|
2021
Q1 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 1198 |
|
2020
Q1 | – | Sell |
-10
| Closed | -$4K | – | 1148 |
|
2019
Q4 | $4K | Hold |
10
| – | – | ﹤0.01% | 604 |
|
2019
Q3 | $3K | Sell |
10
-2
| -17% | -$600 | ﹤0.01% | 601 |
|
2019
Q2 | $4K | Sell |
12
-2
| -14% | -$667 | ﹤0.01% | 571 |
|
2019
Q1 | $4K | Sell |
14
-2
| -13% | -$571 | ﹤0.01% | 567 |
|
2018
Q4 | $4K | Sell |
16
-2
| -11% | -$500 | ﹤0.01% | 447 |
|
2018
Q3 | $6K | Sell |
18
-3
| -14% | -$1K | ﹤0.01% | 449 |
|
2018
Q2 | $6K | Sell |
21
-3
| -13% | -$857 | ﹤0.01% | 416 |
|
2018
Q1 | $6K | Buy |
+24
| New | +$6K | ﹤0.01% | 395 |
|